Coversyl



Indications and Reactions:

Role Indications Reactions
Primary
Ill-defined Disorder 57.9%
Drug Use For Unknown Indication 21.9%
Hypertension 7.4%
Product Used For Unknown Indication 3.4%
Cardiac Failure Congestive 1.9%
Prophylaxis 1.7%
Cardiac Failure 0.7%
Depression 0.6%
Essential Hypertension 0.6%
Drug Exposure During Pregnancy 0.6%
Type 2 Diabetes Mellitus 0.6%
Hypertensive Cardiomyopathy 0.5%
Atrial Fibrillation 0.4%
Myocardial Infarction 0.4%
Nasopharyngitis 0.4%
Coronary Artery Disease 0.3%
Epilepsy 0.3%
Hypercholesterolaemia 0.3%
Anaemia 0.2%
Angina Pectoris 0.2%
Renal Failure Acute 13.9%
Hyperkalaemia 8.3%
Urinary Retention 6.9%
Orthostatic Hypotension 5.6%
Renal Failure 5.6%
Respiratory Distress 5.6%
Sciatica 5.6%
Urinary Tract Infection 5.6%
Ventricular Fibrillation 5.6%
Pulmonary Oedema 4.2%
Somnolence 4.2%
Therapeutic Agent Toxicity 4.2%
Toxic Skin Eruption 4.2%
Weight Decreased 4.2%
Abnormal Behaviour 2.8%
Acute Pulmonary Oedema 2.8%
Angina Pectoris 2.8%
Dysphagia 2.8%
Eczema 2.8%
Jaundice 2.8%
Secondary
Drug Use For Unknown Indication 29.2%
Hypertension 19.8%
Product Used For Unknown Indication 17.6%
Ill-defined Disorder 5.7%
Angina Pectoris 4.0%
Type 2 Diabetes Mellitus 3.4%
Diabetes Mellitus 2.8%
Hypercholesterolaemia 2.5%
Prophylaxis 1.8%
Back Pain 1.7%
Cardiac Disorder 1.5%
Dyslipidaemia 1.3%
Myocardial Infarction 1.3%
Thrombosis Prophylaxis 1.3%
Gastritis Prophylaxis 1.2%
Atrial Fibrillation 1.1%
Premedication 1.1%
Acute Coronary Syndrome 1.0%
Hiv Infection 1.0%
Cardiac Failure 0.9%
Renal Failure Acute 16.9%
Vomiting 10.8%
Toxic Skin Eruption 7.7%
Renal Failure 6.7%
Jaundice 5.6%
Hyponatraemia 5.1%
Liver Function Test Abnormal 5.1%
Thrombocytopenia 5.1%
Urticaria 4.6%
Pancreatitis Acute 4.1%
Colitis Ischaemic 3.6%
Fall 3.6%
Vascular Purpura 3.6%
Pruritus 3.1%
Rales 3.1%
Orthostatic Hypotension 2.6%
Shock 2.6%
Angioedema 2.1%
Neutropenia 2.1%
Pyrexia 2.1%
Concomitant
Drug Use For Unknown Indication 23.1%
Hypertension 18.1%
Product Used For Unknown Indication 16.8%
Rheumatoid Arthritis 5.5%
Prophylaxis 4.0%
Atrial Fibrillation 3.7%
Diabetes Mellitus 3.0%
Cardiac Failure 2.9%
Hiv Infection 2.8%
Depression 2.6%
Osteoporosis 2.6%
Pain 2.3%
Crohn's Disease 2.1%
Hypercholesterolaemia 1.9%
Type 2 Diabetes Mellitus 1.7%
Thrombosis Prophylaxis 1.6%
Non-small Cell Lung Cancer 1.5%
Acute Coronary Syndrome 1.4%
Psoriasis 1.4%
Asthma 1.2%
Vomiting 11.4%
Thrombocytopenia 9.6%
Renal Failure 9.1%
Renal Failure Acute 6.7%
Myocardial Infarction 6.5%
Pyrexia 6.2%
Weight Decreased 5.3%
Weight Increased 4.5%
International Normalised Ratio Increased 4.2%
Fall 3.8%
Rhabdomyolysis 3.8%
Pain In Extremity 3.6%
Syncope 3.6%
Ventricular Tachycardia 3.6%
Nausea 3.1%
Oedema Peripheral 3.1%
Rash 3.1%
Somnolence 3.1%
Cytolytic Hepatitis 2.9%
Hyponatraemia 2.9%
Interacting
Ill-defined Disorder 43.5%
Drug Use For Unknown Indication 19.6%
Hypertension 10.9%
Localised Infection 5.4%
Cardiomyopathy 4.3%
Cardiac Failure 3.3%
Essential Hypertension 3.3%
Rheumatoid Arthritis 3.3%
Type 2 Diabetes Mellitus 3.3%
Ankylosing Spondylitis 1.1%
Arthralgia 1.1%
Blood Cholesterol 1.1%
Nitritoid Crisis 17.6%
Drug Interaction 11.8%
Hyperkalaemia 11.8%
Renal Failure Acute 11.8%
Somnolence 11.8%
Blood Creatinine Increased 5.9%
Pain In Extremity 5.9%
Stent Placement 5.9%
Urticaria 5.9%
Ventricular Tachycardia 5.9%
Vomiting 5.9%